Please wait

 

 

Dr. Reddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills

Hyderabad – 500 034, Telangana, India

 

CIN: L85195TG1984PLC004507

 

Tel:       + 91 40 4900 2900

Fax:     + 91 40 4900 2999

Email: mail@drreddys.com

Web:   www.drreddys.com

 

January 24, 2026

 

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

 

Dear Sir/Madam,

 

Ref:

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

 

This is to inform that Dr. Reddy’s Laboratories LLC, Russia, a step-down wholly-owned subsidiary of Dr. Reddy’s Laboratories Limited has received tax audit decision on January 23, 2026, from The Interdistrict Inspectorate of the Federal Tax Service of Russia. The details as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 are as hereunder:

 

S. No.

Name of the authority

:

The Interdistrict Inspectorate of the Federal Tax Service of Russia.

1

Nature and details of the action(s) taken, or order(s) passed

:

Dr. Reddy’s Laboratories LLC, Russia, a step-down wholly-owned subsidiary of Dr. Reddy’s Laboratories Limited received a tax audit decision from The Interdistrict Inspectorate of the Federal Tax Service of Russia.

2

Date of receipt of direction or order, including any ad-interim or interim orders, or any other communication from the authority

:

Tax audit decision received by the Company on January 23,2026.

3

Details of the violation(s)/ contravention(s) committed or alleged to be committed

:

Levy of Value Added Tax (VAT) upon re-classification of marketing services as taxable services by the authority.

4

Impact on financial, operation or other activities of the listed entity, quantifiable in monetary terms to the extent possible

:

The authority has quantified a penalty of Rub million 20.09 [INR 24.50 million].

 

Based on our evaluation, there is no material impact on the financials, operations, or other activities of the Company

 

The Company will evaluate filing necessary reply to the authority in this regard.

 

This is for your information and records.

 

Thanking you,

 

Yours faithfully,

For Dr. Reddy’s Laboratories Limited


K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR